Termination Agreement between AIM Immunotech, Inc. and Shenzhen Smoore Technology Limited
AIM Immunotech, Inc. and Shenzhen Smoore Technology Limited have mutually agreed to end their Material Transfer and Research Agreement, along with its supplemental extension, effective August 10, 2022. This decision was confirmed by both parties following recent communications. The agreement, originally set to expire on May 31, 2023, is now terminated ahead of schedule, releasing both parties from their obligations under the original and supplemental agreements.
Exhibit 10.88
Termination Agreement
Further and pursuant to the Material Transfer and Research Agreement signed on April 1, 2020 and the Supplemental Extension agreement signed on May 21, 2021 due to expire on May 31, 2023, the Parties agreed pursuant to our last email communication to terminate the Agreement as of August 10, 2022.
AIM IMMUNOTECH, INC.
| By: | /s/Peter W. Rodino | |
| Date : | August 10, 2022 | |
| Name: | Peter W. Rodino | |
| Title : | General Counsel |
SHENZHEN SMOORE TECHNOLOGY LIMITED
| By: | /s/Zhiqiang Shi | |
| Date: | August 10, 2022 | |
| Name: | Zhiqiang Shi | |
| Title : | Global R&D Director (Smoore International) |
